The U.S. PRP and stem cell alopecia treatment market size was valued at USD 212.7 million in 2023 and is anticipated to exhibit a CAGR of 5.4% from 2024 to 2030. This growth is attributed to the increasing number of people suffering from alopecia and rising awareness of novel treatment p... Read More »
September 2024The global HPV associated disorders market size was estimated at USD 17.6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2030. The WHO highlights HPV as one of the most common sexually transmitted infections, leading to serious healt... Read More »
September 2024The global amyotrophic lateral sclerosis treatment market size was estimated at USD 667.3 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030. The increasing incidence and prevalence of amyotrophic lateral sclerosis (ALS), particular... Read More »
September 2024The global age-related macular degeneration market size was valued at USD 10.82 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. The launch of new products, strong product pipeline, and increase in the prevalence rate of AMD are anticipated to be the major dr... Read More »
September 2024The global urothelial cancer drugs market size was valued at USD 3.24 billion in 2023 and is anticipated to grow at a CAGR of 11.1% from 2024 to 2030. This growth is driven by the rising prevalence of urothelial cancer, particularly bladder cancer. Innovations in cancer treatment, such a... Read More »
September 2024The Asia Pacific radiopharmaceuticals market size was valued at USD 1.91 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2030. The increasing prevalence of chronic diseases such as cancer and cardiovascular conditions has heightened ... Read More »
September 2024The global congestive heart failure drugs market size was valued at USD 7.69 billion in 2023 and is projected to grow at a CAGR of 14.6% from 2024 to 2030. The aging population with increased life expectancy, rising prevalence of heart failure and cardiovascular diseases, increasing R&am... Read More »
September 2024The Asia Pacific biopharma excipient market size was valued at USD 761.2 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. This growth is attributed to the region's expanding pharmaceutical industry, advancements in functional excipients, and the rising use of... Read More »
September 2024The global schizophrenia drugs market size was valued at USD 7.90 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. The increasing demand is due to the rising prevalence of schizophrenia and other related mental health disorders worldwide. This increase can be... Read More »
September 2024The Brazil sports nutrition market size was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. There is a growing prevalence of various lifestyle diseases such as diabetes, cardiovascular diseases, and obesity in Brazil. For instance, accordi... Read More »
September 2024The global artemisinin combination therapy market size was valued at USD 597.2 million in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. It is attributed to the rising malaria in various regions. Malaria remains a significant public health challenge, with millions of ... Read More »
September 2024The global cold plasma market size was valued at USD 128.9 million in 2023 and is projected to grow at a CAGR of 15.8% from 2024 to 2030. This growth is attributed to the overall development of the healthcare industry, which has increased the demand for advanced technologies to enhance p... Read More »
September 2024The global cervical cancer treatment market size was valued at USD 8.16 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030. This growth is attributed to advancements in oncology technology, increasing incidence of cervical cancer, recent advancements in imaging ... Read More »
September 2024The China liver cancer drug market size was valued at USD 209.91 million in 2023 and is projected to grow at a CAGR of 20.6% from 2024 to 2030, driven by the increasing incidence of the disease, advancements in treatment modalities, growing awareness, and early diagnostic practices in th... Read More »
September 2024The global general anesthesia drugs market size was estimated at USD 5.1 billion in 2023 and is projected to grow at a CAGR of 3.7% from 2024 to 2030. This growth is primarily fueled by the increasing volume of surgical procedures, advancements in anesthesia technology, and the rising pr... Read More »
September 2024The U.S. general anesthesia drugs market size was estimated at USD 1.67 billion in 2023 and is projected to grow at a CAGR of 2.8% from 2024 to 2030. This growth is fueled by several key factors, including a rising number of surgical procedures, technological advancements in anesthesia, ... Read More »
September 2024The global acne drugs market size was valued at USD 9.22 billion in 2023 and is projected to grow at a CAGR of 5.2% from 2024 to 2030. The driving factors of the growth include the increasing prevalence of acne, lifestyle changes, rising skin awareness, and growing cosmetic concerns. Acn... Read More »
September 2024The North America topical skin treatment market size was estimated at USD 6.64 billion in 2023 and is projected to grow at a CAGR of 9.60% from 2024 to 2030. The market growth can be attributed to the increasing prevalence of skin conditions, advancements in treatment options, and strate... Read More »
September 2024The global cerebral infarction treatment market size was estimated at USD 12.4 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2030. This growth is driven by rising prevalence of cerebrovascular diseases, advancements in medical technology, increased healthcare sp... Read More »
September 2024The China lung cancer therapeutics market size is estimated at USD 2.18 billion in 2023 and is projected to grow at a CAGR of 13.7% from 2024 to 2030. The increasing incidence of lung cancer, growing awareness and screening initiatives, and adoption of targeted therapies in the country, ... Read More »
September 2024